Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
BACKGROUND: Natural killer (NK) cells play a key role in immune surveillance and response to tumors, their function regulated by NK cell receptors and their ligands. The DNAM-1 activating receptor recognizes the CD155 molecule expressed in several tumor cells, such as hepatocellular carcinoma (HCC). This study aims to investigate the role of the DNAM-1/CD155 axis in mediating the NK cell response in patients with HCC.
METHODS: Soluble CD155 was measured by ELISA. CD155 expression was sought in HCC cells by immunohistochemistry, qPCR, and flow cytometry. DNAM-1 modulation in NK cells was evaluated in transwell experiments and by a siRNA-mediated knockdown. NK cell functions were examined by direct DNAM-1 triggering.
RESULTS: sCD155 was increased in sera from HCC patients and correlated with the parameters of an advanced disease. The expression of CD155 in HCC showed a positive trend toward better overall survival. DNAM-1 downmodulation was induced by CD155-expressing HCC cells, in agreement with lower DNAM-1 expressions in tumor-infiltrating NK (NK-TIL) cells. DNAM-1-mediated cytotoxicity was defective both in circulating NK cells and in NK-TIL of HCC patients.
CONCLUSIONS: We provide evidence of alterations in the DNAM-1/CD155 axis in HCC, suggesting a possible mechanism of tumor resistance to innate immune surveillance.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Cancers - 14(2022), 16 vom: 22. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mantovani, Stefania [VerfasserIn] |
---|
Links: |
---|
Themen: |
DNAM-1 |
---|
Anmerkungen: |
Date Revised 30.08.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/cancers14164060 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345294459 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345294459 | ||
003 | DE-627 | ||
005 | 20231226024734.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cancers14164060 |2 doi | |
028 | 5 | 2 | |a pubmed24n1150.xml |
035 | |a (DE-627)NLM345294459 | ||
035 | |a (NLM)36011052 | ||
035 | |a (PII)4060 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mantovani, Stefania |e verfasserin |4 aut | |
245 | 1 | 0 | |a Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.08.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGROUND: Natural killer (NK) cells play a key role in immune surveillance and response to tumors, their function regulated by NK cell receptors and their ligands. The DNAM-1 activating receptor recognizes the CD155 molecule expressed in several tumor cells, such as hepatocellular carcinoma (HCC). This study aims to investigate the role of the DNAM-1/CD155 axis in mediating the NK cell response in patients with HCC | ||
520 | |a METHODS: Soluble CD155 was measured by ELISA. CD155 expression was sought in HCC cells by immunohistochemistry, qPCR, and flow cytometry. DNAM-1 modulation in NK cells was evaluated in transwell experiments and by a siRNA-mediated knockdown. NK cell functions were examined by direct DNAM-1 triggering | ||
520 | |a RESULTS: sCD155 was increased in sera from HCC patients and correlated with the parameters of an advanced disease. The expression of CD155 in HCC showed a positive trend toward better overall survival. DNAM-1 downmodulation was induced by CD155-expressing HCC cells, in agreement with lower DNAM-1 expressions in tumor-infiltrating NK (NK-TIL) cells. DNAM-1-mediated cytotoxicity was defective both in circulating NK cells and in NK-TIL of HCC patients | ||
520 | |a CONCLUSIONS: We provide evidence of alterations in the DNAM-1/CD155 axis in HCC, suggesting a possible mechanism of tumor resistance to innate immune surveillance | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a DNAM-1 | |
650 | 4 | |a PVR | |
650 | 4 | |a hepatocellular carcinoma | |
650 | 4 | |a natural killer cells | |
700 | 1 | |a Varchetta, Stefania |e verfasserin |4 aut | |
700 | 1 | |a Mele, Dalila |e verfasserin |4 aut | |
700 | 1 | |a Maiello, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Donadon, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Soldani, Cristiana |e verfasserin |4 aut | |
700 | 1 | |a Franceschini, Barbara |e verfasserin |4 aut | |
700 | 1 | |a Torzilli, Guido |e verfasserin |4 aut | |
700 | 1 | |a Tartaglia, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Maestri, Marcello |e verfasserin |4 aut | |
700 | 1 | |a Piccolo, Gaetano |e verfasserin |4 aut | |
700 | 1 | |a Barabino, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Opocher, Enrico |e verfasserin |4 aut | |
700 | 1 | |a Bernuzzi, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Mondelli, Mario U |e verfasserin |4 aut | |
700 | 1 | |a Oliviero, Barbara |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 14(2022), 16 vom: 22. Aug. |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:16 |g day:22 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers14164060 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 16 |b 22 |c 08 |